Johan Hansson

7.2k total citations
151 papers, 4.8k citations indexed

About

Johan Hansson is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Johan Hansson has authored 151 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 95 papers in Oncology, 52 papers in Molecular Biology and 50 papers in Immunology. Recurrent topics in Johan Hansson's work include Cutaneous Melanoma Detection and Management (59 papers), Immunotherapy and Immune Responses (38 papers) and Melanoma and MAPK Pathways (25 papers). Johan Hansson is often cited by papers focused on Cutaneous Melanoma Detection and Management (59 papers), Immunotherapy and Immune Responses (38 papers) and Melanoma and MAPK Pathways (25 papers). Johan Hansson collaborates with scholars based in Sweden, United Kingdom and Germany. Johan Hansson's co-authors include Rolf Kiessling, Giuseppe Masucci, Isabel Poschke, Ulrik Ringborg, Dimitrios Mougiakakos, Lars Bastholt, Ulrika Stierner, Yago Pico de Coaña, Steinar Aamdal and Lena Kanter‐Lewensohn and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Johan Hansson

148 papers receiving 4.7k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Johan Hansson 2.9k 1.9k 1.6k 477 373 151 4.8k
Robyn P.M. Saw 3.8k 1.3× 1.5k 0.8× 1.8k 1.2× 498 1.0× 643 1.7× 178 5.1k
Pippa Corrie 3.0k 1.0× 802 0.4× 1.5k 1.0× 499 1.0× 638 1.7× 176 4.8k
Jacob Schachter 6.5k 2.2× 3.0k 1.6× 3.0k 1.9× 748 1.6× 690 1.8× 189 8.4k
Johan Hansson 2.3k 0.8× 631 0.3× 3.5k 2.2× 901 1.9× 404 1.1× 107 5.4k
Ning Lü 1.5k 0.5× 973 0.5× 1.3k 0.8× 689 1.4× 398 1.1× 244 6.1k
Dan Jones 1.9k 0.7× 1.1k 0.6× 1.7k 1.1× 252 0.5× 590 1.6× 256 8.6k
Steinar Aamdal 4.1k 1.4× 2.4k 1.2× 3.0k 1.9× 461 1.0× 632 1.7× 130 6.6k
Ahmad A. Tarhini 5.6k 1.9× 3.6k 1.9× 2.4k 1.5× 437 0.9× 508 1.4× 276 8.0k
Lia Gore 2.6k 0.9× 743 0.4× 2.6k 1.6× 632 1.3× 235 0.6× 202 6.1k
David Polsky 3.7k 1.3× 833 0.4× 3.9k 2.5× 1.1k 2.4× 727 1.9× 124 6.8k

Countries citing papers authored by Johan Hansson

Since Specialization
Citations

This map shows the geographic impact of Johan Hansson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johan Hansson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johan Hansson more than expected).

Fields of papers citing papers by Johan Hansson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johan Hansson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johan Hansson. The network helps show where Johan Hansson may publish in the future.

Co-authorship network of co-authors of Johan Hansson

This figure shows the co-authorship network connecting the top 25 collaborators of Johan Hansson. A scholar is included among the top collaborators of Johan Hansson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johan Hansson. Johan Hansson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Das, Ishani, Rainer Tuominen, Thomas Helleday, et al.. (2021). Coexpression of MTH1 and PMS2 Is Associated with Advanced Disease and Disease Progression after Therapy in Melanoma. Journal of Investigative Dermatology. 142(3). 736–740.e6. 6 indexed citations
2.
Helgadóttir, Hildur, Yvonne Brandberg, Johan Hansson, et al.. (2020). TRIM study protocol - a prospective randomized multicenter Trial to assess the Role of Imaging during follow-up after radical surgery of stage IIB-C and III cutaneous malignant Melanoma. BMC Cancer. 20(1). 1197–1197. 8 indexed citations
3.
Das, Ishani, Helge Gad, Lars Bräutigam, et al.. (2020). AXL and CAV-1 play a role for MTH1 inhibitor TH1579 sensitivity in cutaneous malignant melanoma. Cell Death and Differentiation. 27(7). 2081–2098. 21 indexed citations
4.
Das, Ishani, Huiqin Chen, Gianluca Maddalo, et al.. (2020). Inhibiting insulin and mTOR signaling by afatinib and crizotinib combination fosters broad cytotoxic effects in cutaneous malignant melanoma. Cell Death and Disease. 11(10). 882–882. 14 indexed citations
5.
Blank, Christian U., Elisa A. Rozeman, Alexander M. Menzies, et al.. (2018). OpACIN-neo: A multicenter phase II study to identify the optimal neo-adjuvant combination scheme of ipilimumab (IPI) and nivolumab (NIVO). Annals of Oncology. 29. viii734–viii734. 12 indexed citations
6.
Das, Ishani, Helge Gad, Lars Bräutigam, et al.. (2018). 1180 Effects of MTH1 inhibitor TH1579 on cutaneous melanoma. Journal of Investigative Dermatology. 138(5). S200–S200. 2 indexed citations
7.
Hansson, Johan, et al.. (2017). Primary tumor sites in relation to ultraviolet radiation exposure and skin visibility correlate with survival in cutaneous melanoma. International Journal of Cancer. 141(7). 1345–1354. 7 indexed citations
8.
Lyth, Johan, Eva Månsson‐Brahme, Margareta Frohm‐Nilsson, et al.. (2016). Prognostic factors and disease-specific survival among immigrants diagnosed with cutaneous malignant melanoma in Sweden. International Journal of Cancer. 139(3). 543–553. 11 indexed citations
9.
Sekulović, Lidija Kandolf, Ketty Peris, Axel Hauschild, et al.. (2016). More than 5000 patients with metastatic melanoma in Europe per year do not have access to new life-saving drugs. Annals of Oncology. 27. vi586–vi586. 3 indexed citations
10.
Schwaederlé, Maria, Vladimir Lazar, Pierre Validire, et al.. (2015). VEGF-A Expression Correlates with TP53 Mutations in Non–Small Cell Lung Cancer: Implications for Antiangiogenesis Therapy. Cancer Research. 75(7). 1187–1190. 96 indexed citations
11.
Lyth, Johan, Hanna Eriksson, Johan Hansson, et al.. (2014). Trends in cutaneous malignant melanoma in Sweden 1997-2011: thinner tumours and improved survival among men. British Journal of Dermatology. 172(3). 700–706. 30 indexed citations
12.
Coaña, Yago Pico de, Isabel Poschke, Giusy Gentilcore, et al.. (2013). Ipilimumab Treatment Results in an Early Decrease in the Frequency of Circulating Granulocytic Myeloid-Derived Suppressor Cells as well as Their Arginase1 Production. Cancer Immunology Research. 1(3). 158–162. 110 indexed citations
13.
Omholt, Katarina, Ismini Vassilaki, Veronica Höiom, et al.. (2013). KIT, NRAS, BRAF and PTEN mutations in a sample of Swedish patients with acral lentiginous melanoma. Journal of Dermatological Science. 72(3). 284–289. 71 indexed citations
14.
Mao, Yumeng, Isabel Poschke, Erik Wennerberg, et al.. (2013). Melanoma-Educated CD14+ Cells Acquire a Myeloid-Derived Suppressor Cell Phenotype through COX-2–Dependent Mechanisms. Cancer Research. 73(13). 3877–3887. 157 indexed citations
15.
Omholt, Katarina, et al.. (2011). KIT Pathway Alterations in Mucosal Melanomas of the Vulva and Other Sites. Clinical Cancer Research. 17(12). 3933–3942. 135 indexed citations
16.
Poschke, Isabel, Dimitrios Mougiakakos, Johan Hansson, Giuseppe Masucci, & Rolf Kiessling. (2010). Immature Immunosuppressive CD14+HLA-DR−/low Cells in Melanoma Patients Are Stat3hi and Overexpress CD80, CD83, and DC-Sign. Cancer Research. 70(11). 4335–4345. 329 indexed citations
17.
Jönsson, Anders, et al.. (2010). High Frequency of p16 Promoter Methylation in NRAS-Mutated Cutaneous Melanoma. Journal of Investigative Dermatology. 130(12). 2809–2817. 46 indexed citations
18.
Emeny, J. M., Johan Hansson, Rune Toftgård, & Dan Segerbäck. (2008). Meeting Report of the Conference on UV-Radiation-Induced Disease—Roles of UVA and UVB. Journal of Investigative Dermatology. 128(8). 1875–1877. 1 indexed citations
19.
Matsuda, Masanori, Max Petersson, Giuseppe Masucci, et al.. (1994). Interleukin 10 pretreatment protects target cells from tumor- and allo-specific cytotoxic T cells and downregulates HLA class I expression.. The Journal of Experimental Medicine. 180(6). 2371–2376. 263 indexed citations
20.
Schoultz, E. von, et al.. (1994). Estramustine binding protein in primary tumours and metastases of malignant melanoma. Melanoma Research. 4(6). 401–405. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robyn P.M. Saw Breakdown of academic impact, for papers by Pippa Corrie Breakdown of academic impact, for papers by Jacob Schachter Breakdown of academic impact, for papers by Johan Hansson Breakdown of academic impact, for papers by Ning Lü Breakdown of academic impact, for papers by Dan Jones Breakdown of academic impact, for papers by Steinar Aamdal Breakdown of academic impact, for papers by Ahmad A. Tarhini Breakdown of academic impact, for papers by Lia Gore Breakdown of academic impact, for papers by David Polsky
Rankless by CCL
2026